Novo Nordisk's next-gen weight loss drug outperforms Zepbound in new trial
Source: thehill.com ·
Section: politics ·
Bias: Center
· Published: Mon, 28 Sep 2026 12:23:31 GMT
Novo Nordisk says its potential Wegovy successor helped patients lose more weight than Zepbound in a major clinical trial.
Read the full article at thehill.com →
← Back to FlashTopics.com